Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
Stockchase Opinions

David BaskinInex Pharmaceuticals CorpIEX.TODON'T BUYApr 04, 2003

Need to get FDA approval. Too speculative for their funds.
$3.69

Stock price when the opinion was issued

biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

COMMENT
This is a penny stock and they tend to be promoted.
BUY
A well-run company. Probably one of the lower risk biotech investments in Canada. Their product Onco TCS should be approved this year. Have a good marketing partnership with Enzon.
BUY
If you like biotechs, this could be OK. Speculative.
HOLD
Good cash balance. Their problemsare delays in getting their product to market. Needs a good partner.
BUY
Needs approval by FDA. Nice cash balance.
DON'T BUY
There will be some delay in their filings with FDA.
WEAK BUY
In phase 3 trials. Speculative.
PAST TOP PICK
(Was a top pick on Dec 5 no change) Still likes.
TOP PICK
A speculative choice, but has a good RISK/RETURN.
BUY
Just partnered which is good. Good company